Related Experiment Video
Updated: Jun 26, 2026

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Commentary to the letter of Dr Cesare de Gregorio
Insights
Left ventricular thrombus in tako-tsubo cardiomyopathy is rare but treatable with anticoagulants. Early anticoagulant therapy is recommended for prevention and management of these serious cardiac complications.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Internal Medicine
Background:
- Tako-tsubo cardiomyopathy (TTC) is a stress-induced cardiac dysfunction.
- Left ventricular thrombus (LVT) and cardioembolism are known, albeit rare, complications of TTC.
Discussion:
- Systematic review by de Gregorio et al. analyzed LVT in TTC patients.
- Anticoagulant therapy demonstrated efficacy in treating LVT and preventing cardioembolic events.
Key Insights:
- LVT formation in TTC is a rare but significant complication.
- Anticoagulant therapy is an effective treatment for LVT in TTC.
- Prophylactic use of anticoagulants may prevent LVT development.
Outlook:
- Further research into optimal anticoagulant strategies for TTC patients.
- Consideration of routine anticoagulant use in TTC patients with identified mural thrombus.
- Investigating the long-term benefits and risks of anticoagulation in TTC.
Abstract:
In a recent systematic review, de Gregorio et al. reported that left ventricular thrombus formation and subsequent cardioembolism in patients with tako-tsubo cardiomyopathy are rare but well-defined complications that can be efficaciously treated with anticoagulant therapy. These data underline the need for the routine use of anticoagulant drugs when mural thrombus formation occurs and suggest the use of these drugs to prevent such complications.
Related Concept Videos
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Standards of Care II
Cerebrum: Anatomical Overview II
Castigliano's Theorem
Correspondence Bias
Methods of Documentation III: PIE

